Cryopoint
Cryopoint is a Brownsburg, Indiana-based cryogenic biorepository and lab-processing provider offering FDA-registered, AABB-accredited sample storage to universities, biotechs, hospitals, pharma, and physician groups, alongside consumer cord blood (Cryocyte), fertility (Cryopoint Fertility Group), sperm (SpermCryo), and dental stem cell banking (Tooth Bank) sub-brands.
- Company typePrivate
- Founded2011
- HeadquartersBrownsburg, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Cryopoint does
Cryopoint is a privately-held cryogenic sample management and biorepository services provider headquartered in Brownsburg, Indiana, founded in 2011 by Michael A. Byers. The company operates from a single facility located approximately 15 minutes from the FedEx hub at Indianapolis International Airport, a location chosen for its low natural-disaster risk profile. The core platform combines liquid-nitrogen cryogenic storage with 24-hour video surveillance, motion-sensor detection, and real-time, uneditable temperature monitoring to provide tamper-evident chain-of-custody for biological samples. Under the Cryopoint parent brand the company sells B2B biorepository contracts and custom clinical/research lab processing services to universities, biotech firms, hospital networks, physician groups, and pharmaceutical corporations.
Cryopoint monetizes through a portfolio of wholly-owned sub-brands, each addressing a distinct cryogenic end-market. Cryocyte offers FDA-regulated, AABB-accredited private umbilical cord blood and cord tissue banking for expecting parents; Cryopoint Fertility Group sells subscription-based storage for embryos, oocytes/ovarian tissue, and sperm at publicly disclosed rates (e.g., $38/month or $1,700 for 5 years prepaid); SpermCryo is a dedicated sperm cryostorage site; and the related Tooth Bank provides dental stem cell banking. The company combines a subscription/recurring revenue model on the consumer side with managed-services contracts on the B2B side, and operates a fertility-clinic referral channel that drives bottom-of-funnel patient signups.
The company is HIPAA compliant, FDA registered, and AABB accredited, with medical and laboratory direction provided by Dr. Michael J. Bauer (MD, FACP, CTBS). It positions itself as the industry-lowest-priced full-quality cryogenic provider, supported by a 30% cancer-patient discount program and a deliberate single-site geographic strategy that leverages FedEx logistics for 24-48 hour nationwide sample shipment. The business is founder-centric, with Michael A. Byers serving as President, CEO, and Managing Member across all four operating brands.
Cryopoint firmographics
Firmographics- Name
- Cryopoint
- Legal name
- Cryopoint, LLC
- Website
- https://cryopointllc.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cryopoint is a Brownsburg, Indiana-based cryogenic biorepository and lab-processing provider offering FDA-registered, AABB-accredited sample storage to universities, biotechs, hospitals, pharma, and physician groups, alongside consumer cord blood (Cryocyte), fertility (Cryopoint Fertility Group), sperm (SpermCryo), and dental stem cell banking (Tooth Bank) sub-brands.
- Ownership category
- akta.pro rank
Cryopoint industry classification
Industry- Product category
- Biorepository & Cryogenic Sample Storage Services
- NAICS
- Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industries
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)
Keywords
Where Cryopoint is headquartered
LocationHeadquarters
- HQ city
- Brownsburg
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Cryopoint business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Fertility storage subscriptions: Recurring storage fees for embryos, oocytes/ovarian tissue, and sperm, billed monthly or prepaid for 1, 3, or 5 year terms. Pricing is the same for all tissue types, with a premium for potentially infectious samples. Includes a 30% discount for cancer patients (up to 2 years).
- Private cord blood and umbilical cord banking (Cryocyte): One-time and recurring private banking fees for umbilical cord blood and cord tissue (mesenchymal stem cells) collected at birth for future medical use.
- Biorepository / B2B sample storage contracts: Long-term storage contracts for universities, biotech firms, hospital networks, physician groups, and pharmaceutical corporations. Includes tissue procurement and storage lifecycle management services.
- Clinical & research laboratory services: Custom-tailored clinical and research lab processing projects for biotech and research clients, structured as project-based professional services engagements.
- Cancer storage at discounted rates: Discounted cancer sample storage rates as part of company mission to reduce life-saving treatment costs (referenced as part of corporate giving in founder letter).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Monthly standard storage for fertility samples (embryos, oocytes, sperm) |
| Subscription | Annual | 1 Year Prepaid fertility storage |
| Subscription | Multi-year contract | 3 Years Prepaid fertility storage |
| Subscription | Multi-year contract | 5 Years Prepaid fertility storage |
| Subscription | Pay-as-you-go | Cancer Patient Program (discounted plans) |
Go-to-market motion5 records
Distribution channels6 records
Marketing channels6 records
Cryopoint product offering
Product offeringCore offering
Cryopoint provides cryogenic sample storage, biorepository services, and clinical/research laboratory processing for bioscience clients, with long-term liquid-nitrogen storage of embryos, oocytes, sperm, cord blood, umbilical cord tissue, and pharmaceutical or research samples. It packages these capabilities under multiple consumer-facing brands (Cryocyte for cord blood, Cryopoint Fertility Group, SpermCryo, Tooth Bank) and serves both individual consumers via subscriptions and B2B clients via storage and lab-services contracts.
Product overview
Cryopoint operates as a parent company with a core biorepository and lab-processing platform, supported by several sub-brands: Cryocyte (private cord blood and umbilical cord banking), Cryopoint Fertility Group (cryogenic storage for embryos, oocytes/ovarian tissue, and sperm), SpermCryo (sperm cryopreservation), and the related Tooth Bank (dental stem cell banking). The core platform delivers tailored sample-storage planning, execution, and 24/7 monitored storage, while each sub-brand delivers a specialized cryogenic storage service to its own customer segment.
Differentiator
Problem solved
Functional benefit
Brands
- Cryocyte: Affordable private cord blood and umbilical cord banking brand (FDA Regulated, AABB Accredited).
- Cryopoint Fertility
- SpermCryo
- Tooth Bank
Products and services
- Cryopoint Biorepository & Lab Processing Core cryogenic biorepository and biostorage service for organizations, with clinical and research laboratory processing, tailored sample-storage planning, execution, and 24/7 monitored liquid-nitrogen storage at a HIPAA-compliant, FDA-registered, AABB-accredited Brownsburg, IN facility. Targets universities, biotech firms, hospital networks, physician groups, and pharmaceutical corporations needing long-term, compliant cryogenic sample storage.
- Cryocyte Private Cord Blood & Umbilical Cord Banking FDA-regulated, AABB-accredited private banking service for umbilical cord blood and umbilical cord tissue (mesenchymal stem cells) collected at birth, offering affordable storage of hematopoietic and mesenchymal stem cells for future medical use. Targets expecting parents seeking private stem cell banking.
- Cryopoint Fertility Group Storage Cryogenic storage service for embryos, oocytes/ovarian tissue, and sperm, marketed at industry-low pricing with 24/7 monitoring and tailored plans for individuals, couples, and fertility clinic referrals. Includes monthly, 1-year, 3-year, and 5-year prepaid tiers, a 30% cancer-patient discount for up to 2 years, and a premium rate for potentially infectious samples.
- SpermCryo Sperm Cryopreservation Dedicated sperm cryopreservation/banking service under the Cryopoint family, targeted at individuals seeking sperm storage for fertility preservation, including those in high-risk professions, active military, cancer patients, and couples in active fertility treatment.
- Tooth Bank Dental Stem Cell Banking Dental stem cell banking service that collects and cryogenically stores stem cells from extracted teeth for future medical use, operated as a separate LLC under common founder ownership with Cryopoint.
Quantifiable outcome
- Industry-lowest published pricing for fertility storage (e.g., $38/month standard, $1,700 for 5 years prepaid)
- +3 more outcomes
Companies that use Cryopoint
Customer profileNamed customers8 records
Segments9 records
Ideal customer profiles2 records
Cryopoint technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Cryopoint partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered flagship sibling brand within the cryopoint family of companies; founded and led by the same ceo, michael a. byers., flagship sibling brand within the cryopoint family of companies., sibling brand in the cryopoint family of companies., sibling brand under the same founder; dental stem cell banking., core go-to-market channel for consumer fertility storage. and critical logistics enabler for nationwide 24-48 hour sample shipment; not a formal partnership but a structural dependency given proximity to fedex hub..
- CryoCyte (Cryocyte, LLC)flagship sibling brand within the cryopoint family of companies; founded and led by the same ceo, michael a. byers.Sister company under common ownership and leadership (CEO/Founder Michael A. Byers). Cryocyte provides FDA Regulated, AABB Accredited private umbilical cord blood banking, and is featured as a flagship offering on the Cryopoint website. The brands cross-link to each other.
- Cryopoint Fertility Groupflagship sibling brand within the cryopoint family of companies.Sister brand focused on fertility sample storage (embryos, oocytes, sperm). Featured prominently on the Cryopoint website. Operates a separate site (fertilitystorage.com) and is run by the same founder.
- SpermCryosibling brand in the cryopoint family of companies.Sister brand for sperm cryostorage with its own dedicated site (spermcryo.com) and Facebook page. Brought under the Cryopoint brand family.
- Tooth Bank, LLCsibling brand under the same founder; dental stem cell banking.Industry-leading dental stem cell banking company, also founded and led by Michael A. Byers (CEO and Founder). Promoted on the Cryopoint homepage as a related service line.
- Fertility Clinics (referral / reseller channel)core go-to-market channel for consumer fertility storage.Cryopoint actively invites fertility clinics to offer its storage service to their patients as a referral relationship. Clinics contact [email protected] to begin a simple, straightforward partnership process.
- FedEx (logistics partner)critical logistics enabler for nationwide 24-48 hour sample shipment; not a formal partnership but a structural dependency given proximity to fedex hub.Proximity to the FedEx hub at Indianapolis International Airport (15 minutes from Cryopoint's Brownsburg, IN facility) is highlighted as a key logistics advantage, supporting 24-48 hour sample delivery to any U.S. location.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Cryopoint competitors and assessment
Company assessmentDirect peers
- Cryoport: Temperature-controlled logistics and biostorage provider for the life sciences industry. Highly comparable as both companies operate cryogenic storage and shipping for pharma, biotech, and reproductive medicine clients, though Cryoport is publicly listed and substantially larger.
- Fairfax Cryobank: Specialty sperm and reproductive tissue cryobank serving fertility clinics and individuals. Directly comparable to Cryopoint's SpermCryo and Cryopoint Fertility Group brands with overlap on donor and patient fertility storage.
- New England Cord Blood Bank: AABB-accredited private and public cord blood banking service. Directly comparable to Cryocyte on FDA/AABB positioning and serving the expecting-parent segment.
- StemCyte: Combined public/private cord blood bank operating U.S. and international facilities. Directly comparable on FDA/AABB-accredited cord blood and tissue banking, with overlap on Cryocyte's positioning.
- Cord Blood Registry (CBR): Largest U.S. private cord blood and cord tissue bank. Directly comparable to Cryopoint's Cryocyte brand on private cord blood banking with FDA/AABB-grade processing, competing on price and quality for expecting parents.
- ViaCord (Revvity): Private cord blood and cord tissue banking service. Direct competitor to Cryocyte with comparable FDA/AABB positioning, serving the same expecting-parent segment at premium price points.
- Cryos International: International sperm and donor tissue bank. Comparable to SpermCryo and Cryopoint Fertility on cryogenic storage of reproductive samples, with overlap in serving fertility clinics and individual consumers.
- BioLife Solutions: Supplier of biopreservation media, storage tools, and cold-chain services for cell and gene therapies. Comparable on cryopreservation focus and customer base (biotech, pharma) though oriented around consumables and tools rather than storage services.
Broad incumbents
- Azenta Life Sciences (formerly Brooks Life Sciences): Large-scale sample storage, biorepository, and cold-chain services for pharma, biotech, and academic clients. Overlaps with Cryopoint's B2B biorepository offering as a much larger, established incumbent with global footprint.
- Thermo Fisher Scientific (Bioservices & CryoEM): Diversified life sciences leader offering biorepository, bioservices, and cryogenic storage solutions as part of a much larger portfolio. Directly relevant to Cryopoint's B2B pharma/biotech and academic segments, though not a specialty storage pure-play.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Cryopoint social profiles
Digital presenceCryopoint compliance and trust
Trust signalCompliance3 records
Cryopoint financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cryopoint leadership team
Management profileNumber of profiles
Profiles2 records
Cryopoint subsidiaries and ownership
Company hierarchySubsidiaries4 records
Cryopoint funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cryopoint M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cryopoint
What does Cryopoint do?
Cryopoint provides cryogenic sample storage, biorepository services, and clinical/research laboratory processing for bioscience clients, with long-term liquid-nitrogen storage of embryos, oocytes, sperm, cord blood, umbilical cord tissue, and pharmaceutical or research samples. It packages these capabilities under multiple consumer-facing brands (Cryocyte for cord blood, Cryopoint Fertility Group, SpermCryo, Tooth Bank) and serves both individual consumers via subscriptions and B2B clients via storage and lab-services contracts.
Is Cryopoint a public or private company?
Cryopoint is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cryopoint founded?
Cryopoint was founded in 2011. It employs 11 to 50 people.
Where is Cryopoint based?
Cryopoint is headquartered in Brownsburg, United States, in the North America region.
How does Cryopoint make money?
Five revenue lines are on record. Fertility storage subscriptions are the primary driver. The others are private cord blood and umbilical cord banking (Cryocyte), biorepository / B2B sample storage contracts, clinical & research laboratory services and cancer storage at discounted rates.
Who are Cryopoint's main competitors?
Direct peers on record are Cryoport, Fairfax Cryobank, New England Cord Blood Bank, StemCyte, Cord Blood Registry (CBR), ViaCord (Revvity), Cryos International and BioLife Solutions. Broad incumbents are Azenta Life Sciences (formerly Brooks Life Sciences) and Thermo Fisher Scientific (Bioservices & CryoEM).
Does Cryopoint have an API?
No public API is recorded for Cryopoint.
What industry is Cryopoint in?
Cryopoint's product category is Biorepository & Cryogenic Sample Storage Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 621991 and its SIC code is 8731.